Cite
S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection.
MLA
Moreno-Nieves, Uriel Y., et al. “S100A9 Tetramers, Which Are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection.” Frontiers in Immunology, vol. 6, Sept. 2015, p. 478. EBSCOhost, https://doi.org/10.3389/fimmu.2015.00478.
APA
Moreno-Nieves, U. Y., Didier, C., Lévy, Y., Barré-Sinoussi, F., & Scott-Algara, D. (2015). S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection. Frontiers in Immunology, 6, 478. https://doi.org/10.3389/fimmu.2015.00478
Chicago
Moreno-Nieves, Uriel Y, Céline Didier, Yves Lévy, Françoise Barré-Sinoussi, and Daniel Scott-Algara. 2015. “S100A9 Tetramers, Which Are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection.” Frontiers in Immunology 6 (September): 478. doi:10.3389/fimmu.2015.00478.